Mar 9, 2024 04:00PM

Oct 20, 2023 08:01AM

Oct 6, 2023 08:00AM

Sep 20, 2022 11:09AM

Jul 29, 2022 04:05PM

Jul 11, 2022 08:04AM

Mar 25, 2022 07:31AM Arcutis Biotherapeutics Inc. (ARQT) Reports Roflumilast Foam Demonstrates Clinically Meaningful Results and Patient Quality of Life Improvements in Phase 2 Seborrheic Dermatitis Study

Mar 25, 2022 07:30AM

Sep 30, 2021 08:40AM

May 6, 2021 08:46AM

Feb 1, 2021 09:30AM

Feb 1, 2021 07:31AM

Oct 6, 2020 04:05PM

Oct 2, 2020 06:11AM Arcutis Biotherapeutics Inc. (ARQT) Prices 4M Share Common Offering and Concurrent Private Placement

Oct 1, 2020 10:47PM

Sep 29, 2020 04:52PM

Sep 29, 2020 04:51PM

Sep 29, 2020 04:20PM

Sep 29, 2020 08:07AM

Sep 16, 2020 09:14AM

Aug 3, 2020 09:04AM Arcutis Biotherapeutics Inc. (ARQT) Announces Publication of Data from Positive Phase 1/2a Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream)

Jul 15, 2020 05:08PM

Mar 16, 2020 08:47AM

Mar 16, 2020 08:37AM

Mar 16, 2020 08:37AM

Feb 13, 2020 08:33AM

Jan 21, 2020 09:10AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All